Boston Scientific Inc. (BSX): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.3%. By the end of trading, Boston Scientific rose $0.27 (2.1%) to $13.30 on average volume. Throughout the day, 14,839,448 shares of Boston Scientific exchanged hands as compared to its average daily volume of 11,938,400 shares. The stock ranged in a price between $13.05-$13.44 after having opened the day at $13.08 as compared to the previous trading day's close of $13.03. Other companies within the Health Care sector that increased today were: LCA-Vision ( LCAV), up 28.0%, Fonar Corporation ( FONR), up 25.1%, Aoxing Pharmaceutical Company ( AXN), up 15.4% and La Jolla Pharmaceutical ( LJPC), up 11.6%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $17.3 billion and is part of the health services industry. Shares are up 8.4% year to date as of the close of trading on Thursday. Currently there are 8 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet.

On the negative front, Ohr Pharmaceutical ( OHRP), down 18.9%, Dynatronics Corporation ( DYNT), down 16.6%, Galena Biopharma ( GALE), down 14.3% and Tianyin Pharmaceutical ( TPI), down 13.1% , were all laggards within the health care sector with Valeant Pharmaceuticals International ( VRX) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

These Stocks Are Ready to Reverse Course

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Cramer: These Sectors Look Bullish (Part III)